Economic Evaluation of Ciprofloxacin Compared with Usual Antibacterial Care for the Treatment of Acute Exacerbations of Chronic Bronchitis in Patients Followed for 1 Year
- 1 January 1999
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 16 (5) , 499-520
- https://doi.org/10.2165/00019053-199916050-00007
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Exorcising Protocol-induced Spirits:Medical Decision Making, 1997
- Guidelines for Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and MedicineJAMA, 1996
- Canadian Guidelines for Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1996
- Multi-Attribute Preference FunctionsPharmacoEconomics, 1995
- Multi-Attribute Health Status Classification SystemsPharmacoEconomics, 1995
- Drug Prices and Third Party PaymentPharmacoEconomics, 1994
- The St George's Respiratory QuestionnaireRespiratory Medicine, 1991
- The French version of the Nottingham health profile. A comparison of items weights with those of the source versionSocial Science & Medicine, 1990
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987